Johnson & Johnson (NYSE:JNJ) is recalling another set of medicines after its recent recall of Benadryl and Motrin. This time it is over 9 million bottles of Tylenol. This recall is blamed for the unknown quantity of alcohol in the medicines. This alcohol was a part of the flavoring, which the company failed to list on the packaging.
Since there are no adverse effects of the medicine, the medicines are only recalled from distributors and pharmacies. People who have already brought this medicine, do not have to return it to the company. A Johnson & Johnson (NYSE:JNJ) plant in Fort Washington was recently closed because of irregularities in manufacturing practices.
Related posts:
- Gilead Obtaining Approval for HIV Drug
- J&J Recalling Benadryl and Motrin
- Finding The Source of HIV
- Enzymes Causing Breast Cancer Identified
- Increasing Premature Deaths
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.